Charles Y.C. Pak
University of Texas Southwestern Medical Center
386 Papers
6.8K Citations
Charles Y.C. Pak is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Calcium & Hypercalciuria. The author has an hindex of 80, co-authored 386 publications. Previous affiliations of Charles Y.C. Pak include Scott & White Hospital & University of Chicago.
Chat about Author
Papers
Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis
TL;DR: The hypocalciuric action of TZ may lead to improved calcium balance and may potentially attenuate further bone loss in patients with postmenopausal osteoporosis when exogenous 1,25-(OH)2D is provided, according to a three-phase study.
7
An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with paget disease of bone during a short-term diphosphonate therapy
TL;DR: Six patients with Paget disease of bone were treated with disodium-ethane-1-hydroxy-1, 1-diphosphate and EHDP resulted in a significant increase in intestinal calcium absorption that was not correlated with a change in serum 1 alpha, 25-(OH)2-vitamin D concentration.
7
Physical Chemistry of Stone Formation
Charles Y.C. Pak
- 01 Jan 1978
TL;DR: In this article, the physicochemical environment of urine that predisposes to the formation of stones has been defined and applied to establish physicochemical action of various therapeutic regimens for nephrolithiasis and quantifying the response to treatment.
7
Pitfalls in parathyroid evaluation in patients with calcium urolithiasis
TL;DR: Several pitfalls of parathyroid evaluation and treatment are illustrated by four cases of calcium urolithiasis, including the correct diagnosis of primary hyperparathyroidism and the thiazide provocative test.
6
Treatment of vitamin D-resistant hypopara-thyroidism with 25-hydroxycholecalciferol.
TL;DR: The 25-hydroxycholecalciferol (25-HCC) metabolite of vitamin D 3 circulating in the blood was found to increase the gastrointestinal absorption of calcium in patients with hypoparathyroidism as discussed by the authors.
6